Japan-Wide Clinical Trial Network
Increasing cancer clinical trials access for patients in Japan
A strategic partnership between Fujitsu and Paradigm will create an ecosystem that comprehensively supports the entire clinical trial process, from trial design and study startup to recruitment and execution of clinical trials across Japan.
|
 |
|
|
|
|
|
|
|
|
Paradigm Partners with Fujitsu to Solve Clinical Trials in Japan "When I founded Paradigm it was with a similar vision to what Fujitsu is solving with Uvance Healthy Living - that every single patient should have access to the best possible care for their disease inclusive of a clinical trial as a care option," said Kent Thoelke, Chief Executive Officer, Paradigm. "No patient should lack the access to these treatment options as a result of where they live, their ethnic background, their socioeconomic status, or the physician or medical institution where they are being treated. This includes the disparities created by the drug loss problem created by global clinical trial development strategies." Read more |
|
|
Fujitsu Tackles ‘Drug Loss’ in Japan Through Ecosystem to Accelerate Digitalization of Clinical Trials Kawasaki, August 26, 2024 - Fujitsu today announced that it will begin initiatives to attract global clinical trials to Japan and tackle the “Drug Loss” by working with pharmaceutical companies and medical institutions to build a new medical data ecosystem. The efforts come under the Fujitsu Uvance Healthy Living, which aims to improve people’s well-being. In July 2024, Fujitsu executed a strategic partnership agreement with Paradigm Health, Inc., a US startup that provides one of the world’s most advanced clinical trial platforms. Through utilizing this platform, Fujitsu’s Healthy Living Platform, and the Fujitsu Kozuchi AI service, Fujitsu and Paradigm will facilitate the collection and processing of data stored at medical institutions and speed up the clinical trial planning process. Read more |
